Last reviewed · How we verify
NCT06607965
Whey Protein and Carbohydrates in ERAS for Recovery After Thyroidectomy: A Cohort Study
NA trial testing Whey Protein and Carbohydrates in Whey Protein in 127 participants. Completed in 31 May 2024.
31 March 2024
Quick facts
| Lead sponsor | Chongqing General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 127 |
| Start date | 1 March 2023 |
| Primary completion | 31 March 2024 |
| Estimated completion | 31 May 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Whey Protein and Carbohydrates
Conditions studied
- Whey Protein — all drugs for Whey Protein →
- Thyroid Neoplasms — all drugs for Thyroid Neoplasms →
- Neck Dislocation — all drugs for Neck Dislocation →
- Enhanced Recovery After Surgery — all drugs for Enhanced Recovery After Surgery →
Sponsor
Chongqing General Hospital
Who can join
18 and older, any sex, with Whey Protein or Thyroid Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Exploring the effects of whey protein combined with carbohydrates in an Enhanced Recovery After Surgery (ERAS) protocol on the postoperative recovery of thyroid cancer patients undergoing lateral neck dissection, aiming to provide more precise research and guidance for the perioperative accelerated recovery plan in such patients. The goal is to accelerate postoperative recovery and reduce postoperative complications for thyroid cancer patients undergoing neck dissection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06607965
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Whey Protein
Currently open trials in the same condition.
- NCT07011225 — Effects of Rehabilitation and Supplementation With Hydrolyzed Collagen vs. Whey Protein on the Cardiopulmonary, Renal, M · Phase 4 · active not recruiting
Other Chongqing General Hospital trials
Trials by the same sponsor.
- NCT06868758 — Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer · active not recruiting
- NCT06793579 — Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06607965 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chongqing General Hospital
- Last refreshed: 3 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06607965.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing